Olema Pharmaceuticals Inc
OLMA5.410USD
+0.080+1.50%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
5.410USD+5.410After-hours (ET)
369.68MMarket Cap
LossP/E TTM
Olema Pharmaceuticals Inc
5.410
+0.080+1.50%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q2
FY2020Q1
FY2019Q4
Operating expenses
1.56%34.87M
20.88%36.77M
61.17%37.62M
55.22%33.53M
16.00%34.34M
11.75%30.42M
0.52%23.34M
-35.12%21.60M
27.30%29.60M
25.10%27.22M
30.74%23.22M
101.51%33.29M
50.51%23.25M
114.76%21.76M
--17.76M
564.60%16.52M
1381.30%15.45M
896.17%10.13M
--2.49M
--1.04M
--1.02M
R&D expenses
2.48%30.62M
24.84%32.30M
70.80%33.23M
61.82%29.11M
30.92%29.88M
19.87%25.87M
10.36%19.45M
-33.51%17.99M
42.58%22.83M
35.11%21.58M
40.76%17.63M
127.15%27.05M
49.73%16.01M
154.01%15.97M
--12.52M
511.71%11.91M
1244.91%10.69M
591.10%6.29M
--1.95M
--795.00K
--910.00K
Depreciation, depletion, and amortization
45.45%128.00K
31.82%116.00K
5.56%95.00K
-5.05%94.00K
-12.00%88.00K
-9.28%88.00K
-1.10%90.00K
16.47%99.00K
19.05%100.00K
32.88%97.00K
82.00%91.00K
174.19%85.00K
833.33%84.00K
1725.00%73.00K
--50.00K
1450.00%31.00K
200.00%9.00K
33.33%4.00K
--2.00K
--3.00K
--3.00K
Operating profit
-1.56%-34.87M
-20.88%-36.77M
-61.17%-37.62M
-55.22%-33.53M
-16.00%-34.34M
-11.75%-30.42M
-0.52%-23.34M
35.12%-21.60M
-27.30%-29.60M
-25.10%-27.22M
-30.74%-23.22M
-101.51%-33.29M
-50.51%-23.25M
-114.76%-21.76M
---17.76M
-564.60%-16.52M
-1381.30%-15.45M
-896.17%-10.13M
---2.49M
---1.04M
---1.02M
Net non-operating interest income (expenses)
Non-operating interest income
34.96%4.52M
-7.24%3.29M
52.58%2.93M
100.52%3.11M
156.86%3.35M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.30M
792.66%973.00K
492.38%622.00K
254.70%415.00K
96.40%218.00K
10800.00%109.00K
--105.00K
254.55%117.00K
3600.00%111.00K
--1.00K
--33.00K
--3.00K
--0.00
Non-operating interest expense
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
-100.00%0.00
--0.00
--0.00
--653.00K
--0.00
Special income (expenses)
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
Other non-operating income (expenses)
-335.29%-40.00K
-200.00%-93.00K
274.68%138.00K
190.91%40.00K
54.55%17.00K
38.81%93.00K
34.17%-79.00K
-320.00%-44.00K
83.33%11.00K
570.00%67.00K
-114.29%-120.00K
2100.00%20.00K
--6.00K
1100.00%10.00K
---56.00K
---1.00K
----
---1.00K
----
----
--0.00
Income before tax
1.88%-30.39M
-25.38%-33.57M
-60.71%-34.55M
-51.19%-30.38M
-9.49%-30.97M
-2.27%-26.77M
5.36%-21.50M
38.84%-20.09M
-22.82%-28.29M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
-113.58%-21.64M
---17.71M
-568.81%-16.41M
-806.02%-15.34M
-896.17%-10.13M
---2.45M
---1.69M
---1.02M
Income after tax
1.88%-30.39M
-25.38%-33.57M
-60.71%-34.55M
-51.19%-30.38M
-9.49%-30.97M
-2.27%-26.77M
5.36%-21.50M
38.84%-20.09M
-22.82%-28.29M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
-113.58%-21.64M
---17.71M
-568.81%-16.41M
-806.02%-15.34M
-896.17%-10.13M
---2.45M
---1.69M
---1.02M
Net income from continuous operations
1.88%-30.39M
-25.38%-33.57M
-60.71%-34.55M
-51.19%-30.38M
-9.49%-30.97M
-2.27%-26.77M
5.36%-21.50M
38.84%-20.09M
-22.82%-28.29M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
-113.58%-21.64M
---17.71M
-568.81%-16.41M
-806.02%-15.34M
-896.17%-10.13M
---2.45M
---1.69M
---1.02M
Net income attributable to controlling interests
1.88%-30.39M
-25.38%-33.57M
-60.71%-34.55M
-51.19%-30.38M
-9.49%-30.97M
-2.27%-26.77M
5.36%-21.50M
38.84%-20.09M
-22.82%-28.29M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
-113.58%-21.64M
---17.71M
-568.81%-16.41M
-806.02%-15.34M
-896.17%-10.13M
---2.45M
---1.69M
---1.02M
Net income attributable to common shareholders
1.88%-30.39M
-25.38%-33.57M
-60.71%-34.55M
-51.19%-30.38M
-9.49%-30.97M
-2.27%-26.77M
5.36%-21.50M
38.84%-20.09M
-22.82%-28.29M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
-113.58%-21.64M
---17.71M
-568.81%-16.41M
-806.02%-15.34M
-896.17%-10.13M
---2.45M
---1.69M
---1.02M
Basic earnings per share
36.17%-0.36
8.55%-0.45
-26.23%-0.60
-9.39%-0.54
20.50%-0.56
25.25%-0.49
15.76%-0.48
40.05%-0.49
-21.24%-0.70
-19.64%-0.65
-26.90%-0.57
-97.76%-0.82
-48.22%-0.58
-107.00%-0.54
---0.45
-553.63%-0.42
-787.49%-0.39
-896.25%-0.26
---0.06
---0.04
---0.03
Diluted earnings per share
36.17%-0.36
8.55%-0.45
-26.23%-0.60
-9.39%-0.54
20.50%-0.56
25.25%-0.49
15.76%-0.48
40.05%-0.49
-21.24%-0.70
-19.64%-0.65
-26.90%-0.57
-97.76%-0.82
-48.22%-0.58
-107.00%-0.54
---0.45
-553.63%-0.42
-787.49%-0.39
-896.25%-0.26
---0.06
---0.04
---0.03
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
